The weekend of “eye grass” Aier Eye Hospital Group Co.Ltd(300015) was not very peaceful. ” Aier Eye Hospital Group Co.Ltd(300015) three year operation rebate details were exposed” rushed to microblog hot search.
Source: microblog
From January 6 to January 9, AI Fen, who was certified as “director of emergency department of Wuhan Central Hospital”, successively posted four lists on the microblog called “emergency Zhejiang Sunflower Great Health Limited Liability Company(300111) AI Fen”, including Aier Eye Hospital Group Co.Ltd(300015) bribe “hospital doctor’s name, referring person’s position, contact person, amount of money, account opening bank, card number, patient’s name, operation date, disease type, operation fee, etc, Aifen questioned Aier Eye Hospital Group Co.Ltd(300015) the existence of “bribery” of doctors.
Suqian Aier Eye Hospital Group Co.Ltd(300015) hospital issued a statement on January 9, saying: according to the information transmitted online, our hospital has carried out rectification according to the relevant requirements of the board of directors in 2019, seriously dealt with the illegal employees and replaced the management team.
It is understood that the hospital involved in the list disclosed by the network this time is Suqian Kekang Aier five sense organs hospital, which was renamed Suqian Aier Eye Hospital Group Co.Ltd(300015) hospital Co., Ltd. on November 26, 2021.
Aier Eye Hospital Group Co.Ltd(300015) told China Securities Journal that Suqian Aier Eye Hospital Group Co.Ltd(300015) hospital Co., Ltd. is not a holding subsidiary of Aier Eye Hospital Group Co.Ltd(300015) , but a hospital authorized by Aier group to use the brand.
exposed to bribery
The title of these four lists is the seasonal wage account of borrowing in 2017 and 2019. The diseases of patients include femtosecond wave difference, cataract, full flight, etc. the operation date is concentrated in 2017-2019. The positions of the referrer involve doctors and employees in many hospitals, public officials in many regions, street and township public officials.
In addition, Aifen also exposed several internal policy documents. Among them, a document with “Yulin Aier Eye Hospital Group Co.Ltd(300015) hospital” records in detail the price of hospital diseases and the introduction and reward of employees. For example, the price of corneal transplantation is 29000 yuan / monocular, and the reward for employee introduction is 600 yuan.
company emergency response
On January 9, Suqian Aier Eye Hospital Group Co.Ltd(300015) hospital issued a statement saying that according to the information transmitted on the Internet, the hospital had carried out rectification according to the relevant requirements of the board of directors in 2019, seriously dealt with the illegal employees and replaced the management team. The current leadership took this as a lesson to further strengthen hospital management and adhere to standardized operation. At the same time, strengthen the daily education of employees and improve the service level.
At the same time, Suqian Aier Eye Hospital Group Co.Ltd(300015) hospital expressed its deep regret for the impact caused by this matter. The hospital will sincerely accept the supervision of the media and society.
Source: official account of WeChat Aier Eye Hospital Group Co.Ltd(300015) hospital in Suqian
share price nearly halved in half a year
According to the data, Aier Eye Hospital Group Co.Ltd(300015) was established in 2003. Its main business is diagnosis and treatment of various ophthalmic diseases, surgical services and medical optometry.
After 12 years of listing, the performance and market value of Aier Eye Hospital Group Co.Ltd(300015) have soared all the way. In 2020, the company’s operating revenue will exceed 10 billion yuan. The latest financial report shows that in the first three quarters of 2021, the company achieved an operating revenue of RMB 11.596 billion, a year-on-year increase of 35.38%; The net profit attributable to the shareholders of the listed company was 2.003 billion yuan, a year-on-year increase of 29.59%.
With the growth of performance, the company’s share price also rose all the way, and reached an all-time high of 72.27 yuan / share in July 2021. At that time, the market value of the company once exceeded 450 billion yuan.
However, Aier Eye Hospital Group Co.Ltd(300015) share price then began to fluctuate downward. As of the closing on January 7, the company’s share price was 38.73 yuan / share, with a market value of 209.4 billion yuan, down 46.41% from the previous high.
After hours on January 6, Aier Eye Hospital Group Co.Ltd(300015) issued an announcement on increasing the holdings of directors, supervisors and senior executives. The announcement shows that Liu Duoyuan, deputy general manager and chief financial officer of the company, and Wu Shijun, director, deputy general manager and Secretary of the board of directors of the company, increased their holdings of the company’s shares based on their confidence in the future development prospects of the company and their reasonable judgment on the current internal value of the company. Among them, Liu Duoyuan increased the company’s shares by 102800 shares, accounting for 0.002% of the company’s total share capital; Wu Shijun increased his holdings of 50000 shares in the company, accounting for 0.001% of the total share capital of the company.
(source: China Securities Journal)
